mannuronic acid has been researched along with Multiple Sclerosis, Chronic Progressive in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hosseini, M; Manouchehrinia, A; Matsuo, H; Mirshafiey, A; Moghadam, NB; Mohammadi, AV; Najafi, S; Noorbakhsh, SM; Saadat, P | 1 |
1 trial(s) available for mannuronic acid and Multiple Sclerosis, Chronic Progressive
| Article | Year |
|---|---|
A controlled, randomized phase II clinical trial for efficacy and safety evaluation of mannuronic acid in secondary progressive form of multiple sclerosis.
Topics: Adult; Hexuronic Acids; Humans; Interferon beta-1a; Interferon beta-1b; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Young Adult | 2022 |